Vasogin (VAS.TO)

WEAK BUY
Interesting product line. New issue has diluted the price. Will take a long time.
DON'T BUY
Quite risky. No earnings.
WEAK BUY
Good company and good science. Moving into phase 2 and could take a while.Good pipeline.
TOP PICK
Strong balance sheet and good management. Has a product in phase 3. Good price.
TOP PICK
Good cash position. Partnership with Quest. Strong management.
BUY
Strong balance sheet. Good products going through the FDA trials, one in phase 3. At a good price.
PAST TOP PICK
(Was a top pick on Nov 22 down 17%) A news driven stock re: clinical trials. At a good price.
BUY
At a good price.
BUY
Strong cash position. Nice joint venture. Strong management.
TOP PICK
New joint venture with US company is good. At a good price.
TOP PICK
In a joint venture with Quest which is good. Good risk/reward.
BUY
Looks good. Put a stop loss at $9.
DON'T BUY
Good products in final phase, but a one trick pony.
PAST TOP PICK
(Was a top pick on Aug 29/00 down 15%) Has been up. At an excellent price. Buy.
TOP PICK
A number of products in different phases. Lots of cash.
Showing 16 to 30 of 34 entries